Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06435975
Status:
COMPLETED
Last Update Posted:
2024-05-30
First Post:
2024-05-06
Brief Title:
Physical Activity in Rectal Cancer Survivors
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Abramson Cancer Center at Penn Medicine
Study Overview
Official Title:
Pilot Study of Physical Activity Intervention to Manage Bowel Dysfunction in Rectal Cancer Survivors
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to test a telehealth-based personalized physical activity intervention in adult patients diagnosed with Stage I-III rectal cancer The main question it aims to answer are how to better understand the experiences of rectal cancer survivors who are coping with bowel dysfunction and how physical activity can improve their quality of life
Participants will be asked to
1 Complete surveys to assess bowel function and quality of life
2 Participate in 12 Telehealth Sessions one session a week to discuss and review bowel dysfunction
3 Perform daily physical activity
Participants will be asked to
1 Complete surveys to assess bowel function and quality of life
2 Participate in 12 Telehealth Sessions one session a week to discuss and review bowel dysfunction
3 Perform daily physical activity
Detailed Description:
The goal of this clinical trial is to administer and determine the feasibility of a personalized physical activity intervention for rectal cancer survivors Structured physical activity interventions will be administered over a three-month period An exit interview will be conducted at the completion of this time period
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 849585 | OTHER | Abramson Cancer Center of the University of Pennsylvania | None |